For Healthcare Professionals
In this section you will find information including Summary of Product Characteristics (SPC) and Product Information Leaflets (PIL) for our products in both the United Kingdom (UK) and the Republic of Ireland (ROI). If you require further information regarding one of our products, please use the Medical Information Enquiry Form.
Reporting Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/
In the Republic of Ireland please go to www.hpra.ie/.
Alternatively search for the MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Eisai Ltd on one of the options below:
+44 (0)208 600 1400
EUmedinfo@eisai.net

Oncology
Neurology
-
Leqembi ®
lecanemab SPC UKRisk minimisation materials PIL UK -
Perampanel Eisai
perampanel SPC Tablets UKSPC Suspension UK PIL Tablets UKPIL Suspension UK -
Fycompa ®
perampanel SPC Tablets ROISPC Suspension ROI PIL Tablets ROIPIL Suspension ROI -
Rufinamide Eisai
rufinamide SPC Tablets UKSPC Suspension UK PIL Tablets UKPIL Suspension UK -
Inovelon ®
rufinamide SPC Tablets ROISPC Suspension ROI PIL Tablets ROIPIL Suspension ROI -
Aricept ®
donepezil hydrochloride SPC UK PIL UK -
Aricept Evess ®
donepezil hydrochloride SPC UK PIL UK